Fang Junjun, Pan Zongfu, Yu Hao, Yang Si, Hu Xiaoping, Lu Xiaoyang, Li Lu
Surgical Intensive Critical Care Unit, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.
Department of Pharmacy, Zhejiang Provincial People's Hospital, Zhejiang, China.
Front Pharmacol. 2021 Jan 21;11:575765. doi: 10.3389/fphar.2020.575765. eCollection 2020.
Acute type A aortic dissection (ATAAD) is a life-threatening disease. The understanding of its pathogenesis and treatment approaches remains unclear. In the present work, differentially expressed genes (DEGs) from two ATAAD datasets GSE52093 and GSE98770 were filtered. Transcription factor TEAD4 was predicted as a key modulator in protein-protein interaction (PPI) network. Weighted correlation network analysis (WGCNA) identified five modules in GSE52093 and four modules in GSE98770 were highly correlated with ATAAD. 71 consensus DEGs of highly correlated modules were defined and functionally annotated. L1000CDS was executed to predict drug for drug repositioning in ATAAD treatment. Eight compounds were filtered as potential drugs. Integrative analysis revealed the interaction network of five differentially expressed miRNA and 16 targeted DEGs. Finally, master DEGs were validated in human ATAAD samples and AD cell model . TIMP3 and SORBS1 were downregulated in ATAAD samples and AD cell model, while PRUNE2 only decreased . Calcium channel blocker and glucocorticoid receptor agonist might be potential drugs for ATAAD. The present study offers potential targets and underlying molecular mechanisms ATAAD pathogenesis, prevention and drug discovery.
急性A型主动脉夹层(ATAAD)是一种危及生命的疾病。对其发病机制和治疗方法的理解仍不清楚。在本研究中,从两个ATAAD数据集GSE52093和GSE98770中筛选出差异表达基因(DEG)。转录因子TEAD4被预测为蛋白质-蛋白质相互作用(PPI)网络中的关键调节因子。加权相关网络分析(WGCNA)在GSE52093中识别出五个模块,在GSE98770中识别出四个与ATAAD高度相关的模块。定义了高度相关模块的71个共有DEG并进行了功能注释。执行L1000CDS以预测ATAAD治疗中药物重新定位的药物。筛选出八种化合物作为潜在药物。综合分析揭示了五个差异表达的miRNA和16个靶向DEG的相互作用网络。最后,在人ATAAD样本和AD细胞模型中验证了主要DEG。TIMP3和SORBS1在ATAAD样本和AD细胞模型中下调,而PRUNE2仅降低。钙通道阻滞剂和糖皮质激素受体激动剂可能是ATAAD的潜在药物。本研究为ATAAD发病机制、预防和药物发现提供了潜在靶点和潜在分子机制。